{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:25:38Z","timestamp":1790393138405,"version":"4.1.0"},"reference-count":147,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["#R01CA196973"],"award-info":[{"award-number":["#R01CA196973"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001368","name":"V Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003194","name":"New York Stem Cell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003194","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2017.00265","type":"journal-article","created":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T04:33:47Z","timestamp":1510547627000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":93,"title":["Inflammatory Signaling Pathways in Preleukemic and Leukemic Stem Cells"],"prefix":"10.3389","volume":"7","author":[{"given":"Shayda","family":"Hemmati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamanna","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kira","family":"Gritsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,11,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1200\/JCO.2011.40.7379","article-title":"Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes","volume":"30","author":"Bejar","year":"2012","journal-title":"J Clin Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1182\/blood-2016-10-695940","article-title":"Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms","volume":"129","author":"Vainchenker","year":"2017","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1038\/leu.2014.211","article-title":"Pre-leukemic evolution of hematopoietic stem cells: the importance of early mutations in leukemogenesis","volume":"28","author":"Corces-Zimmerman","year":"2014","journal-title":"Leukemia"},{"key":"B4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.5966\/sctm.2012-0109","article-title":"Concise review: preleukemic stem cells: molecular biology and clinical implications of the precursors to leukemia stem cells","volume":"2","author":"Pandolfi","year":"2013","journal-title":"Stem Cells Transl Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12185-017-2266-5","article-title":"Impact of inflammation on early hematopoiesis and the microenvironment","volume":"106","author":"Takizawa","year":"2017","journal-title":"Int J Hematol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/gerona\/glu057","article-title":"Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases","volume":"69","author":"Franceschi","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/leu.2016.12","article-title":"Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both","volume":"30","author":"Koschmieder","year":"2016","journal-title":"Leukemia"},{"key":"B10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nature14131","article-title":"Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells","volume":"520","author":"Walter","year":"2015","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2017.09.008","article-title":"Impact of DNA methylation programming on normal and pre-leukemic hematopoiesis","author":"Langstein","year":"2017","journal-title":"Semin Cancer Biol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2017.08.001","article-title":"Tet2 restrains inflammatory gene expression in macrophages","author":"Cull","year":"2017","journal-title":"Exp Hematol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"E1490","DOI":"10.1073\/pnas.1616420114","article-title":"Dnmt3a restrains mast cell inflammatory responses","volume":"114","author":"Leoni","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B17","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nrd2422","article-title":"Interferons at age 50: past, current and future impact on biomedicine","volume":"6","author":"Borden","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"B18","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.cytogfr.2007.06.015","article-title":"The role of interferon-alpha in the treatment of chronic myeloid leukemia","volume":"18","author":"Kujawski","year":"2007","journal-title":"Cytokine Growth Factor Rev"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classifiation of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1080\/17474086.2016.1231571","article-title":"Long-acting interferon for myeloproliferative neoplasms \u2013 an update","volume":"9","author":"Pai","year":"2016","journal-title":"Expert Rev Hematol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"28570","DOI":"10.1074\/jbc.M011685200","article-title":"The p38 MAPK pathway mediates the growth inhibiory effects of interferon-a in BCR-ABL-expressing ells","volume":"276","author":"Mayer","year":"2001","journal-title":"J Biol Chem"},{"key":"B22","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1080\/10428190290016782","article-title":"Signaling via the interferon-\u03b1 receptor in chronic myelogenous leukemia cells","volume":"43","author":"Verma","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"B23","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nature07815","article-title":"IFN\u03b1 activates dormant haematopoietic stem cells in vivo","volume":"458","author":"Essers","year":"2009","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1182\/blood-2013-04-498956","article-title":"JAK2V617F expression in mice amplifies early hematopoietic cells and gives them a competitive advantage that is hampered by IFN\u03b1","volume":"122","author":"Hasan","year":"2013","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1182\/blood-2012-05-432989","article-title":"Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-\u03b1 in a murine model of polycythemia vera","volume":"121","author":"Mullally","year":"2013","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.3324\/haematol.2009.010629","article-title":"High rates of durable response are achieved with imatinib after treatment with interferon a plus cytarabine: results from the International Randomized Study of Interferon and STI571 (IRIS) trial","volume":"94","author":"Guilhot","year":"2009","journal-title":"Haematologica"},{"key":"B27","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.exphem.2015.05.013","article-title":"Comparative long-term effects of interferon alpha and hydroxyurea on human hematopoietic progenitor cells","volume":"43","author":"King","year":"2015","journal-title":"Exp Hematol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e0165336","DOI":"10.1371\/journal.pone.0165336","article-title":"Differential dynamics of CALR mutant allele burden in myeloproliferative neoplasms during interferon alpha treatment","volume":"11","author":"Kj\u00e6r","year":"2016","journal-title":"PLoS One"},{"key":"B29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.leukres.2017.01.006","article-title":"Pegylated interferon alpha \u2013 2a is clinically effective and tolerable in myeloproliferative neoplasm patients treated off clinical trial","volume":"54","author":"Gowin","year":"2017","journal-title":"Leuk Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/leu.2015.326","article-title":"Interferon-alpha for the therapy of myeloproliferative neoplasms: targeting the malignant clone","volume":"30","author":"Kiladjian","year":"2016","journal-title":"Leukemia"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.bbmt.2017.04.023","article-title":"IFN-\u03b1 is effective for treatment of minimal residual disease in patients with acute leukemia after allogeneic hematopoietic stem cell transplantation: results of a registry study","volume":"23","author":"Mo","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"B32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.it.2010.12.003","article-title":"Inflammatory signals regulate hematopoietic stem cells","volume":"32","author":"Baldridge","year":"2011","journal-title":"Trends Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1084\/jem.180.3.1177","article-title":"Interferon gamma selectively inhibits very primitive CD342+CD38- and not more mature CD34+CD38+ human hematopoietic progenitor cells","volume":"180","author":"Snoeck","year":"1994","journal-title":"J Exp Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/stem.252","article-title":"Brief report: interferon-gamma induces expansion of Lin(-)Sca-1(+)C-Kit(+) Cells","volume":"28","author":"Zhao","year":"2010","journal-title":"Stem Cells"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1002\/stem.1799","article-title":"Type II interferon promotes differentiation of myeloid-biased hematopoietic stem cells","volume":"32","author":"Matatall","year":"2014","journal-title":"Stem Cells"},{"key":"B36","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nature09135","article-title":"Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection","volume":"465","author":"Baldridge","year":"2010","journal-title":"Nature"},{"key":"B37","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/j.1365-2141.2004.05102.x","article-title":"Homozygosis for (12) CA repeats in the first intron of the human IFN-gamma gene is significantly associated with the risk of aplastic anaemia in Caucasian population","volume":"126","author":"Dufour","year":"2004","journal-title":"Br J Haematol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1038\/sj.leu.2400844","article-title":"Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes","volume":"11","author":"Kitagawa","year":"1997","journal-title":"Leukemia"},{"key":"B39","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1001\/jama.2011.194","article-title":"Targeting immune dysregulation in myelodysplastic syndromes","volume":"305","author":"Olnes","year":"2011","journal-title":"JAMA"},{"key":"B40","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3324\/haematol.13612","article-title":"Immune mediated autologous cytotoxicity against hematopoietic precursor cells in patients with myelodysplastic syndrome","volume":"94","author":"Chamuleau","year":"2009","journal-title":"Haematologica"},{"key":"B41","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1182\/blood-2004-05-2017","article-title":"Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome","volume":"106","author":"Sloand","year":"2005","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/j.1365-2141.2011.08683.x","article-title":"Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapy","volume":"153","author":"Aggarwal","year":"2011","journal-title":"Br J Haematol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1080\/10428194.2016.1219903","article-title":"Increased PD-1\/STAT1 ratio may account for the survival benefit in decitabine therapy for lower risk myelodysplastic syndrome","volume":"58","author":"Zhang","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"B44","doi-asserted-by":"publisher","first-page":"27506","DOI":"10.1074\/jbc.M111.238501","article-title":"Protein kinase R as mediator of the effects of interferon (IFN) gamma and tumor necrosis factor (TNF) alpha on normal and dysplastic hematopoiesis","volume":"286","author":"Sharma","year":"2011","journal-title":"J Biol Chem"},{"key":"B45","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.1038\/onc.2017.85","article-title":"Interferon \u03b3 is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells","volume":"36","author":"Madapura","year":"2017","journal-title":"Oncogene"},{"key":"B46","doi-asserted-by":"publisher","first-page":"25656","DOI":"10.1074\/jbc.M116.753145","article-title":"Interferon-gamma promotes antibody-mediated fratricide of acute myeloid leukemia cells","volume":"291","author":"Fatehchand","year":"2016","journal-title":"J Biol Chem"},{"key":"B47","doi-asserted-by":"publisher","first-page":"14436","DOI":"10.1073\/pnas.1409389111","article-title":"Hematopoietic RIPK1 deficiency results in bone marrow failure caused by apoptosis and RIPK3-mediated necroptosis","volume":"111","author":"Roderick","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/leu.2016.287","article-title":"Sensitizing acute myeloid leukemia cells to induced differentiation by inhibiting the RIP1\/RIP3 pathway","volume":"31","author":"Xin","year":"2017","journal-title":"Leukemia"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/leu.2015.69","article-title":"Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes","volume":"29","author":"Ga\u00f1\u00e1n-G\u00f3mez","year":"2015","journal-title":"Leukemia"},{"key":"B50","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jmb.2006.09.054","article-title":"Signaling through toll-like receptor 7\/8 induces the differentiation of human bone marrow CD34+ progenitor cells along the myeloid lineage","volume":"364","author":"Sioud","year":"2006","journal-title":"J Mol Biol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.immuni.2006.04.008","article-title":"Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment","volume":"24","author":"Nagai","year":"2006","journal-title":"Immunity"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1182\/blood-2011-12-380113","article-title":"Demand-adapted regulation of early hematopoiesis in infection and inflammation","volume":"119","author":"Takizawa","year":"2012","journal-title":"Blood"},{"key":"B53","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.4049\/jimmunol.1003438","article-title":"Chronic exposure to a TLR ligand injures hematopoietic stem cells","volume":"186","author":"Esplin","year":"2011","journal-title":"J Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e55552","DOI":"10.1371\/journal.pone.0055552","article-title":"Chronic TLR signaling impairs the long-term repopulating potential of hematopoietic stem cells of wild type but not Id1 deficient mice","volume":"8","author":"Zhao","year":"2013","journal-title":"PLoS One"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e225","DOI":"10.1016\/j.stem.2017.06.013","article-title":"Pathogen-induced TLR4-TRIF innate immune signaling in hematopoietic stem cells promotes proliferation but reduces competitive fitness","volume":"21","author":"Takizawa","year":"2017","journal-title":"Cell Stem Cell"},{"key":"B56","first-page":"84","article-title":"[Stimulating action of Brucella melitensis lipopolysaccharide on hemopoiesis in mice]","author":"Kaulen","year":"1983","journal-title":"Zh Mikrobiol Epidemiol Immunobiol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/01.shk.0000158960.93832.de","article-title":"The granulopoietic cytokine response and enhancement of granulopoiesis in mice during endotoxemia","volume":"23","author":"Zhang","year":"2005","journal-title":"Shock"},{"key":"B58","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3389\/fimmu.2016.00390","article-title":"The role of toll-like receptors in hematopoietic malignancies","volume":"7","author":"Monlish","year":"2016","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1158\/1078-0432.CCR-06-2108","article-title":"Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes","volume":"13","author":"Maratheftis","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1182\/blood.V100.10.3553","article-title":"Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow","volume":"100","author":"Hofmann","year":"2002","journal-title":"Blood"},{"key":"B61","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.exphem.2015.05.016","article-title":"Deconstructing innate immune signaling in myelodysplastic syndromes","volume":"43","author":"Varney","year":"2015","journal-title":"Exp Hematol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nm.2054","article-title":"Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype","volume":"16","author":"Starczynowski","year":"2010","journal-title":"Nat Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e71120","DOI":"10.1371\/journal.pone.0071120","article-title":"Overexpression of the toll-like receptor (TLR) signaling adaptor MYD88, but lack of genetic mutation, in myelodysplastic syndromes","volume":"8","author":"Dimicoli","year":"2013","journal-title":"PLoS One"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1038\/leu.2013.180","article-title":"Toll-like receptor alterations in myelodysplastic syndrome","volume":"27","author":"Wei","year":"2013","journal-title":"Leukemia"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/nm1638","article-title":"Mrp8 and Mrp14 are endogenous activators of toll-like receptor 4, promoting lethal, endotoxin-induced shock","volume":"13","author":"Vogl","year":"2007","journal-title":"Nat Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nm.4047","article-title":"Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9","volume":"22","author":"Schneider","year":"2016","journal-title":"Nat Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/ni.3654","article-title":"Ubiquitination of hnRNPA1 by TRAF6 links chronic innate immune signaling with myelodysplasia","volume":"18","author":"Fang","year":"2017","journal-title":"Nat Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.cell.2013.06.052","article-title":"Orchestrated intron retention regulates normal granulocyte differentiation","volume":"154","author":"Wong","year":"2013","journal-title":"Cell"},{"key":"B69","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nature12172","article-title":"Single-cell transcriptomics reveals bimodality in expression and splicing in immune cells","volume":"498","author":"Shalek","year":"2013","journal-title":"Nature"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1084\/jem.20141898","article-title":"Loss of Tifab, a del(5q) MDS gene, alters hematopoiesis through derepression of toll-like receptor\u2013TRAF6 signaling","volume":"212","author":"Varney","year":"2015","journal-title":"J. Exp. Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.stem.2016.08.021","article-title":"Mesenchymal inflammation drives genotoxic stress in hematopoietic stem cells and predicts disease evolution in human pre-leukemia","volume":"19","author":"Zambetti","year":"2016","journal-title":"Cell Stem Cell"},{"key":"B72","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/leu.2014.293","article-title":"The role of TLR8 signaling in acute myeloid leukemia differentiation","volume":"29","author":"Ignatz-Hoover","year":"2015","journal-title":"Leukemia"},{"key":"B73","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00262-015-1680-x","article-title":"Augmentation of autologous T cell reactivity with acute myeloid leukemia (AML) blasts by toll-like receptor (TLR) agonists","volume":"64","author":"Zhong","year":"2015","journal-title":"Cancer Immunol Immunother"},{"key":"B74","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Ley","year":"2013","journal-title":"N Engl J Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1182\/blood-2016-09-738005","article-title":"S100A9 induces differentiation of acute myeloid leukemia cells through TLR4","volume":"129","author":"Laouedj","year":"2017","journal-title":"Blood"},{"key":"B76","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/ajh.23280","article-title":"Prolonged subcutaneous administration of 852A, a novel systemic toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced hematologic malignancies","volume":"87","author":"Weigel","year":"2012","journal-title":"Am J Hematol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1158\/1078-0432.CCR-14-1765","article-title":"A phase I study of oral ARRY-614, a p38 MAPK\/Tie2 dual inhibitor, in patients with low or intermediate-1 risk myelodysplastic syndromes","volume":"21","author":"Garcia-Manero","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B78","doi-asserted-by":"publisher","first-page":"E156","DOI":"10.1002\/ajh.23780","article-title":"A phase 2, randomized, double-blind, multicenter study comparing siltuximab plus best supportive care (BSC) with placebo plus BSC in anemic patients with International Prognostic Scoring System low- or intermediation-1-risk myelodysplastic syndrome","volume":"89","author":"Garcia-Manero","year":"2014","journal-title":"Am J Hematol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1158\/1078-0432.CCR-07-4626","article-title":"Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemia","volume":"14","author":"Attar","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.leukres.2013.09.003","article-title":"A phase I study using bortezomib with weekly idarubicin for treatment of elderly patients with acute myeloid leukemia","volume":"37","author":"Howard","year":"2013","journal-title":"Leuk Res"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1002\/pbc.25117","article-title":"A Phase 2 study of bortezomib combined with either idarubicin\/cytarabine or cytarabine\/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children\u2019s Oncology Group","volume":"61","author":"Horton","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"B82","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.blre.2017.05.001","article-title":"Interleukin-1b as emerging therapeutic target in hematological malignancies and potentially in their complications","volume":"31","author":"Arranz","year":"2017","journal-title":"Blood Rev"},{"key":"B83","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.cyto.2013.07.003","article-title":"Interleukin-1 beta is an irradiation-induced stromal growth factor","volume":"64","author":"Bigildeev","year":"2013","journal-title":"Cytokine"},{"key":"B84","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.cyto.2014.10.018","article-title":"Interleukin-1 beta enhances human multipotent mesenchymal stroma cell proliferative potential and their ability to maintain hematopoietic precursor cells","volume":"71","author":"Bigildeev","year":"2015","journal-title":"Cytokine"},{"key":"B85","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/ncb3346","article-title":"Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal","volume":"18","author":"Pietras","year":"2016","journal-title":"Nat Cell Biol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nature21693","article-title":"Myeloid progenitor cluster formation drives emergency and leukaemic myelopoiesis","author":"H\u00e9rault","year":"2017","journal-title":"Nature"},{"key":"B87","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.exphem.2016.09.007","article-title":"Proinflammatory signals are insufficient to drive definitive hematopoietic specification of human HSCs in vitro","volume":"45","author":"Giorgetti","year":"2017","journal-title":"Exp Hematol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1002\/ajh.23295","article-title":"Plasma cytokines in polycythemia vera: phenotypic correlates, prognostic relevance, and comparison with myelofibrosis","volume":"87","author":"Vaidya","year":"2012","journal-title":"Am J Hematol"},{"key":"B89","first-page":"4787","article-title":"IL1RAP as a surface marker for leukemia stem cells is related to clinical phase of chronic myeloid leukemia patients","volume":"7","author":"Zhao","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"B90","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/nature13383","article-title":"Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms","volume":"512","author":"Arranz","year":"2014","journal-title":"Nature"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1182\/blood-2015-11-679928","article-title":"Inhibition of interleukin-1 sinaling enhances elimation of tyrosine kinase inhibitor-treated CML stem cells","volume":"128","author":"Zhang","year":"2016","journal-title":"Blood"},{"key":"B92","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1016\/j.celrep.2016.07.058","article-title":"GATA factor-dependent positive-feedback circuit in acute myeloid leukemia cells","volume":"16","author":"Katsumura","year":"2016","journal-title":"Cell Rep"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/846039","article-title":"Reservatrol downregulates interleukin-6-stimulated sonic hedgehog signaling in human acute myeloid leukemia","volume":"205","author":"Su","year":"2013","journal-title":"Evid Based Comp Alter Med"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/ijc.28198","article-title":"IL-1beta inhibits self-renewal capacity of dormant CD34(+)\/CD38(-) acute myelogenous leukemia cells in vitro and in vivo","volume":"133","author":"Yang","year":"2013","journal-title":"Int J Cancer"},{"key":"B95","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1016\/j.celrep.2017.03.018","article-title":"Identification of interleukin-1 by functional screening as a key mediator of cellular expansion and disease progression in acute myeloid leukemia","volume":"18","author":"Carey","year":"2017","journal-title":"Cell Rep"},{"key":"B96","doi-asserted-by":"publisher","first-page":"20054","DOI":"10.18632\/oncotarget.7911","article-title":"Anti-apoptotic ARC protein confers chemoresistance by controlling leuekemia-microenvironment interactions through a NFkB\/IL1b signaling network","volume":"7","author":"Carter","year":"2016","journal-title":"Oncotarget"},{"key":"B97","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2016.12.011","article-title":"Therapeutic targeting of MLL degradation pathways in MLL-rearranged leukemia","volume":"168","author":"Liang","year":"2017","journal-title":"Cell"},{"key":"B98","doi-asserted-by":"publisher","first-page":"8420","DOI":"10.18632\/oncotarget.14220","article-title":"Sensitizing leukemia stem cells to NF-\u03baB inhibitor treatment in vivo by inactivation of both TNF and IL-1 signaling","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1182\/blood-2012-01-404699","article-title":"Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS","volume":"120","author":"Barreyro","year":"2012","journal-title":"Blood"},{"key":"B100","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1182\/blood-2012-09-458935","article-title":"Selective killing of candidate AML stem cells by antibody targeting of IL1RAP","volume":"121","author":"Askmyr","year":"2013","journal-title":"Blood"},{"key":"B101","doi-asserted-by":"publisher","first-page":"10786","DOI":"10.1073\/pnas.1422749112","article-title":"Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia","volume":"112","author":"Agerstam","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B102","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.bcmd.2013.09.004","article-title":"Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells","volume":"52","author":"McCranor","year":"2014","journal-title":"Blood Cells Mol Dis"},{"key":"B103","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.pharmthera.2013.09.004","article-title":"Targeting interleukin-6 in inflammatory autoimmune diseases","volume":"141","author":"Yao","year":"2014","journal-title":"Pharmacol Ther"},{"key":"B104","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.exphem.2016.10.002","article-title":"HIF1a-induced PDGFRb signaling promotes developmental HSC production via IL-6 activation","volume":"46","author":"Lim","year":"2017","journal-title":"Exp Hematol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.stem.2014.01.007","article-title":"Conversion of danger signals into cytokine signals by hematopoietic stem and progenitor cells for regulation of stress-induced hematopoiesis","volume":"14","author":"Zhao","year":"2014","journal-title":"Cell Stem Cell"},{"key":"B106","doi-asserted-by":"publisher","first-page":"13285","DOI":"10.18632\/oncotarget.7690","article-title":"Increased IL-6 secretion by aged human mesenchymal stromal cells disrupts hematopoietic stem and progenitor cells\u2019 homeostasis","volume":"7","author":"O\u2019Hagan-Wong","year":"2016","journal-title":"Oncotarget"},{"key":"B107","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ccr.2011.10.012","article-title":"IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development","volume":"20","author":"Reynaud","year":"2011","journal-title":"Cancer Cell"},{"key":"B108","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ccell.2015.04.004","article-title":"Treatment of chronic myelogenous leukemia by blocking cytokine alterations found in normal stem and progenitor cells","volume":"27","author":"Welner","year":"2015","journal-title":"Cancer Cell"},{"key":"B109","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1158\/2159-8290.CD-14-0736","article-title":"JAK-STAT pathway activation in malignant and nonmalignant cells contibutes to MPN pathogenesis and therapeutic response","volume":"5","author":"Kleppe","year":"2015","journal-title":"Cancer Discov"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/284706","article-title":"Impact of inflammation on myeloproliferative neoplasm symptom development","volume":"2015","author":"Geyer","year":"2015","journal-title":"Mediators Inflamm"},{"key":"B111","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.scr.2015.09.008","article-title":"The cytokine-mediated crosstalk between primary human acute myeloid cells and mesenchymal stem cells alters the local cytokine network and the global gene expression profile of the mesenchymal cells","volume":"15","author":"Reikvam","year":"2015","journal-title":"Stem Cell Res"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep40707","article-title":"De novo AML exhibits greater microenviroment dysregulation compared to AML with myelodysplasia-related changes","volume":"7","author":"Lopes","year":"2017","journal-title":"Sci Rep"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms17071080","article-title":"The systemic profile of soluble immune mediators in patients with myelodysplastic syndromes","volume":"17","author":"Kittang","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B114","first-page":"50","article-title":"Biochip array technology and evaluation of serum levels of multiple cytokines and adhesion molecules in patients with newly diagnosed acute myeloid leukemia","volume":"36","author":"Horacek","year":"2014","journal-title":"Exp Oncol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature15252","article-title":"Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6","volume":"525","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"B116","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3892\/ijo.2015.3234","article-title":"IL-8, a novel messenger to cross-link inflammation and tumor EMT via autocrine and paracrine pathways","volume":"48","author":"Long","year":"2015","journal-title":"Int J Oncol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/vaccines4030022","article-title":"THe IL-8\/IL-8R axis: a double agent in tumor immune resistance","volume":"4","author":"David","year":"2016","journal-title":"Vaccines (Basel)"},{"key":"B118","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.exphem.2014.01.006","article-title":"Cytokine profiles in polycythemia vera and essential thrombocythemia patients: clinical implications","volume":"42","author":"Pourcelot","year":"2014","journal-title":"Exp Hematol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.imlet.2016.09.004","article-title":"Predictive value of serum cytokine levels in chronic myeloid leukemia patients","volume":"179","author":"Petrackova","year":"2016","journal-title":"Immunol Lett"},{"key":"B120","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1182\/blood-2015-01-621631","article-title":"IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells","volume":"125","author":"Schinke","year":"2015","journal-title":"Blood"},{"key":"B121","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.canlet.2014.03.009","article-title":"Exosome-mediated crosstalk between chronic myelogenous leukemia cells and human bone marrow stromal cells triggers an interleukin-8 dependent survival of leukemia cells","volume":"348","author":"Corrado","year":"2014","journal-title":"Cancer Lett"},{"key":"B122","doi-asserted-by":"publisher","first-page":"18411","DOI":"10.1038\/srep18411","article-title":"IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukemia","volume":"5","author":"Kuett","year":"2015","journal-title":"Sci Rep"},{"key":"B123","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1158\/0008-5472.CAN-16-1095","article-title":"MIF-induced stromal PKCb\/IL8 is essential in human acute myeloid leukemia","volume":"77","author":"Abdul-Aziz","year":"2016","journal-title":"Cancer Res"},{"key":"B124","doi-asserted-by":"publisher","first-page":"43930","DOI":"10.1038\/srep43930","article-title":"Cordycepin disrupts leukemia association with mesenchymal stromal cells and eliminates leukemia stem cell activity","volume":"7","author":"Liang","year":"2017","journal-title":"Sci Rep"},{"key":"B125","first-page":"1005","article-title":"Nuclear factor \u03ba B is activated in myelodysplastic bone marrow cells","volume":"87","author":"Sanz","year":"2002","journal-title":"Haematologica"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1182\/blood-2005-05-1989","article-title":"NF-kappaB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome","volume":"107","author":"Braun","year":"2006","journal-title":"Blood"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/onc.2008.457","article-title":"ATM mediates constitutive NF-kappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia","volume":"28","author":"Grosjean-Raillard","year":"2009","journal-title":"Oncogene"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.exphem.2008.07.012","article-title":"Differential responses of FLIPLong and FLIPShort-overexpressing human myeloid leukemia cells to TNF-alpha and TRAIL-initiated apoptotic signals","volume":"36","author":"Seal","year":"2008","journal-title":"Exp Hematol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.exphem.2007.09.007","article-title":"Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome","volume":"35","author":"Kerbauy","year":"2007","journal-title":"Exp Hematol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"e0158527","DOI":"10.1371\/journal.pone.0158527","article-title":"Reduction of c-Fos via overexpression of miR-34a results in enhancement of TNF- production by LPS in neutrophils from myelodysplastic syndrome patients","volume":"11","author":"Shikama","year":"2016","journal-title":"PLoS One"},{"key":"B131","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1084\/jem.20152008","article-title":"CD70\/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemia","volume":"214","author":"Riether","year":"2017","journal-title":"J Exp Med"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1182\/blood-2015-01-624833","article-title":"Transmembrane TNF-alpha preferentially expressed by leukemia stem cells and blasts is a potent target for antibody therapy","volume":"126","author":"Zhou","year":"2015","journal-title":"Blood"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1128\/MCB.14.2.1039","article-title":"Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors","volume":"14","author":"La Rosa","year":"1994","journal-title":"Mol Cell Biol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1158\/1078-0432.CCR-03-0985","article-title":"Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor gamma in human lung carcinoma cells","volume":"10","author":"Han","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B135","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1172\/JCI0215197","article-title":"Apoptosis and NF-kappa B: the FADD connection","volume":"109","author":"Duckett","year":"2002","journal-title":"J Clin Invest"},{"key":"B136","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.1182\/blood-2005-04-1424","article-title":"NF-kappaB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs)","volume":"106","author":"Kerbauy","year":"2005","journal-title":"Blood"},{"key":"B137","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1172\/JCI68101","article-title":"Positive feedback between NF-kappaB and TNF-alpha promotes leukemia-initiating cell capacity","volume":"124","author":"Kagoya","year":"2014","journal-title":"J Clin Invest"},{"key":"B138","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1182\/blood.V98.8.2301","article-title":"Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells","volume":"98","author":"Guzman","year":"2001","journal-title":"Blood"},{"key":"B139","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1182\/blood-2004-10-4135","article-title":"The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells","volume":"105","author":"Guzman","year":"2005","journal-title":"Blood"},{"key":"B140","doi-asserted-by":"publisher","first-page":"16220","DOI":"10.1073\/pnas.252462599","article-title":"Preferential induction of apoptosis for primary human leukemic stem cells","volume":"99","author":"Guzman","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B141","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ccr.2013.08.019","article-title":"Epigenetic roles of MLL oncoproteins are dependent on NF-kappaB","volume":"24","author":"Kuo","year":"2013","journal-title":"Cancer Cell"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1084\/jem.20130990","article-title":"Co-inhibition of NF-kappaB and JNK is synergistic in TNF-expressing human AML","volume":"211","author":"Volk","year":"2014","journal-title":"J Exp Med"},{"key":"B143","doi-asserted-by":"publisher","first-page":"e93404","DOI":"10.1371\/journal.pone.0093404","article-title":"Overexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-kappaB activation and enhances erythroid differentiation arrest","volume":"9","author":"Ga\u00f1\u00e1n-G\u00f3mez","year":"2014","journal-title":"PLoS One"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1517\/14728222.2013.815728","article-title":"Targeting the ubiquitin-proteasome system for cancer therapy","volume":"17","author":"Shen","year":"2013","journal-title":"Expert Opin Ther Targets"},{"key":"B145","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1365-2141.2010.08319.x","article-title":"The NF (nuclear factor)-kappaB inhibitor parthenolide interacts with histone deacetylase inhibitors to induce MKK7\/JNK1-dependent apoptosis in human acute myeloid leukaemia cells","volume":"151","author":"Dai","year":"2010","journal-title":"Br J Haematol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"38990","DOI":"10.18632\/oncotarget.17166","article-title":"Antineoplastic effects of CPPTL via the ROS\/JNK pathway in acute myeloid leukemia","volume":"8","author":"Gao","year":"2017","journal-title":"Oncotarget"},{"key":"B147","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fonc.2016.00187","article-title":"DNMT3A and TET2 in the pre-leukemic phase of hematopoietic disorders","volume":"6","author":"Sato","year":"2016","journal-title":"Front Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fonc.2017.00265\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T04:33:51Z","timestamp":1510547631000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fonc.2017.00265\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,13]]},"references-count":147,"alternative-id":["10.3389\/fonc.2017.00265"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2017.00265","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,13]]},"article-number":"265"}}